Kenmotsu, H. (2025). Combination of Osimertinib and Vascular Endothelial Growth Factor Receptor Inhibitors for
            <i>EGFR</i>
            -Mutated Non–Small Cell Lung Cancer: Old or New Regimen?. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-01921